A transition metal free tandem two-step strategy has been developed involving hydrolysis of 2-chloro-3-alkynyl quinoxalines/pyrazines followed by in situ cyclization of the corresponding 2-hydroxy-3-alkynyl intermediates in a single pot leading to fused furo N-heterocycles as potential inhibitors of sirtuins. A representative compound showed promising pharmacological properties in vitro and in vivo.
开发了一种无过渡
金属的分段两步策略,该策略涉及2-
氯-3-炔基
喹喔啉/
吡嗪的裂解,随后在单一反应容器中现场环化相应的2-羟基-3-炔基中间体,得到可能作为
去乙酰化酶抑制剂的融合
呋喃N-
杂环化合物。其中一个代表性化合物在体外和体内均显示出有希望的药理学特性。